columbia medicine cme current treatment of mcd and fsgs individualizing therapy
Published 1 year ago • 137 plays • Length 28:49Download video MP4
Download video MP3
Similar videos
-
39:55
columbia medicine cme - novel treatment paradigms for fsgs
-
41:51
columbia medicine cme - treatment opportunities in fsgs and the nephrotic syndrome
-
35:05
columbia medicine cme - novel treatment strategies in lga nephropathy
-
24:53
columbia medicine cme maintenance therapy in anca associated vasculitis
-
3:19
what are the effects of the treatment on cml ?
-
28:56
columbia medicine cme membranous nephropathy how do we utilize pla2r ab and the role of newe
-
26:03
columbia medicine cme iga nephropathy the spectrum of clinical syndromes
-
4:07
focal segmental glomerulosclerosis, causes, signs and symptoms, diagnosis and treatment.
-
1:05:18
mcd vs. fsgs: breakdown of diagnostics and clinical course
-
29:03
abbal koirala, md - rituximab in the management of mcd and immune mediated fsgs
-
5:44
focal segmental glomerulosclerosis - causes, symptoms, diagnosis, treatment, pathology
-
58:48
episode 4 - igan & fsgs series: management, treatment & recommendations for future research in fsgs
-
5:20
old and new ways of understanding fsgs
-
43:41
treating recurrent fsgs in post kidney transplant patients - cme recording
-
5:31
minimal change disease reimagined
-
1:02
mcp 60 seconds with dr hommos and dr fervenza on focal segmental glomerulosclerosis
-
59:25
precision medicines for the treatment of glomerular diseases
-
5:44
minimal change disease (mcd) vs focal segmental glomerulosclerosis (fsgs) | nephrotic syndrome